ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
ALADDIN is a research study to investigate the safety and effectiveness of leuprolide (a hormone drug) to improve the cognitive function and slow the progression of Alzheimer\'s disease (AD). In women leuprolide is commonly used to treat hormone related conditions such as endometriosis and uterine fibroids. The study will include treatment of women 65 years and older with mild to moderate Alzheimer\'s disease who reside in the community.
Epistemonikos ID: bc2e3a4d87490b4e79d69c4a60464a1789e71373
First added on: May 04, 2024